Stewart v. Dominicis

CourtDistrict Court, D. Kansas
DecidedMay 8, 2024
Docket5:24-cv-03058
StatusUnknown

This text of Stewart v. Dominicis (Stewart v. Dominicis) is published on Counsel Stack Legal Research, covering District Court, D. Kansas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Stewart v. Dominicis, (D. Kan. 2024).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF KANSAS

WAYNE ANTHONY STEWART,

Plaintiff,

v. CASE NO. 24-3058-JWL

JORGE A. DOMINICIS, et al.,

Defendants.

MEMORANDUM AND ORDER

This is a pro se civil rights action under 42 U.S.C. § 1983 brought by Plaintiff Wayne Anthony Stewart, who is incarcerated at the Wyandotte County Detention Center (WCDC) in Kansas City, Kansas awaiting civil commitment proceedings. Plaintiff is hereby required to show good cause, in writing, why his claim related to beta blockers should not be dismissed for the reasons stated below. In addition, the Court has determined that proper processing of Plaintiff’s remaining claim, which is related to the treatment of his hepatitis C virus (HCV) cannot be achieved without additional information from appropriate officials at the WCDC. Thus, the Court will direct the appropriate WCDC officials to prepare and submit a Martinez Report. I. Background As Defendants to this action, Plaintiff names Jerry Boyle, the chairman and founder of Correct Care Solutions (CCS), now known as Wellpath, a company that provides medical services for the WCDC; Jorge A. Dominicis, the CEO/President of Wellpath/CCS; Nurse Practitioner and Wellpath employee Amie Fabah-Ezeogu; Nurse Practitioner and Wellpath/CCS employee Alicia Jones; and Registered Nurse Dee Dee Gregory, Wellpath/CCS’s Medical Department Administrator. (Doc. 1, p. 1-3, 5, 7.) Plaintiff alleges the following factual background for his complaint. In 2010, while Plaintiff was previously housed at WCDC, medical staff there were aware that Plaintiff had HCV and they monitored his condition. (Doc. 1-1.) Plaintiff began his current term of confinement at the WCDC on February 8, 2018. (Doc. 1, p. 5, 9.) On November 25, 2018, Plaintiff submitted a grievance seeking treatment of his HCV and expressing his belief that, if untreated, it could “lead to irreversible physical damage and even

life-threatening circumstances.” Id. at 5; (Doc. 1-1, p. 1). Plaintiff stated in that grievance that there was a cure available for HCV. (Doc. 1-1.) The written response to the grievance states: “[Patient] informed that he is currently being monitored in chronic care for this condition. Will schedule [patient] for education with provider.” Id. According to Plaintiff, however, Wellpath’s policy, practice, and custom is to not provide the direct acting antiviral drugs (DAA drugs) that cure HCV because of the cost of those drugs. (Doc. 1, p. 4.) Plaintiff alleges that Defendant Fabah-Ezeogu was following that policy when she denied Plaintiff’s request for the DAA drugs despite knowing that leaving Plaintiff’s HCV untreated posed a substantial risk of serious harm. Id. The denial of the DAA drugs allowed

Plaintiff’s HCV to progress to Stage F4, also called liver cirrhosis. Id. At some point, an unidentified “nursing staff member” told Plaintiff “‘the only reason why the provider is electing not to provide []direct acting antiviral (DAA) treatment is due to the high cost of treatment.’” Id. at 10. On March 25, 2019, Plaintiff submitted an inmate communication form requesting HCV “treatment[/]cure.” (Doc. 1-2.) He explained that he was experiencing nausea, vomiting, fatigue, “extremely ‘light colored’ stools,” and pain in his liver area. He asked to be scheduled for scans or ultrasounds, again asserted that a cure for HCV was available, and asked the medical department to “[p]lease [not] allow my [HCV to] deteriorate into fatal liver cancer.” Id. The written response, which appears to be signed by Defendant Gregory, was “Asked and [a]nswered.” Id. In October 2021, Plaintiff missed a nephrology appointment that had been scheduled with the University of Kansas Health System. (Doc. 1-11.) During a routine medical visit on a Thursday morning sometime prior to December 9, 20221, Plaintiff alleges that his heart rate registered as 39 beats per minute. (Doc. 1, p. 3.) The

nurse who took Plaintiff’s vitals immediately reported the heart rate to Defendant Fabah-Ezeogu, who sent Plaintiff back to his cell. Id. Approximately 24 hours later, a nurse took Plaintiff’s pulse again and discovered that Plaintiff’s heart rate was 37 beats per minutes. After the nurse reported the heart rate to Defendant Fabah-Ezeogu, Defendant Gregory took Plaintiff’s pulse and informed Defendant Fabah-Ezeogu that she recorded 37 beats per minute as well. Id. Plaintiff was sent back to his cell, but approximately 3 hours later, Plaintiff was taken to the University of Kansas Medical Center (UKMC). Id. Doctors at UKMC examined Plaintiff and determined that he “needed a pacemaker or he would die.” Id. Because UKMC did not perform major medical procedures on weekends due to

staffing limitations, the doctors planned to perform the procedure the following Monday morning. In anticipation of the procedure and on the doctors’ orders, Plaintiff stopped taking his usual medications on Saturday. By noon on Sunday, Plaintiff’s heart rate was 111 beats per minute. Id. UKMC doctors informed Plaintiff that he did not need a pacemaker and that his low heart rate was due to a beta blocker he had been taking; Defendant Fabah-Ezeogu had prescribed the beta blocker for Plaintiff. Id. Liberally construing the pro se complaint, it seems that UKMC may have

1 Although Plaintiff does not identify the specific date of these events in his complaint, an inmate communication form he has attached to his complaint that concerns these events is dated December 9, 2022. (Doc. 1-3.) He has also attached an exhibit to the complaint that appears to indicate that these events may have occurred in August 2022. (Doc. 1-6.) recommended testing related to Plaintiff’s HCV; Plaintiff asserts this testing was not done until “recently.” Id. at 6, 9. On December 9, 2022, Plaintiff submitted an inmate communication form regarding his repeated requests for treatment of HCV, the repeated denials of those requests, and his experience with the beta blockers as detailed above. (Doc. 1-3.) He explained that HCV “get[s] wors[e] when

untreated.” Id. The written response, which appears to be signed by Defendant Gregory, was: “Medical follows certain policies and procedures for treatment. The process is reviewed and the provider determines if treatment is clinically indicated or the need to be monitored in the chronic care clinic is sufficient.” Id. On January 25, 2024, Plaintiff submitted a Wellpath health services request stating that he had “asked on several occasions that it be explain[ed] to me the stage of my cirrhosis, and its advance from 2018.” (Doc. 1-12.) Defendant Jones replied, “I am taking the proper [and] necessary steps to get you treatment Mr. Stewart. That’s one of the reasons why your blood keeps getting taken.” Id. On March 20, 2024, Plaintiff signed an informed consent to take Mayvert, “a

medication used to treat the Hepatitis C virus.” (Doc. 1-10.) The provider signature is that of Defendant Jones. Id. The required court-approved form for a complaint under 42 U.S.C. § 1983 has a specific section for Plaintiff to articulate the individual count or counts he wishes to assert in this lawsuit. (Doc. 1, p. 8, 11.) In this section, plaintiffs are instructed to “allege . . . the . . . constitutional rights, privileges or immunities [that] have been violated” in each count and set forth the facts supporting each count. Plaintiff has, instead, written a narrative in these spaces concerning the failure to treat his HCV. See id. Liberally construing the pro se complaint, however, Plaintiff makes two allegations that Defendants violated Plaintiff’s right to adequate medical care and were deliberately indifferent to Plaintiff’s serious medical needs.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Estelle v. Gamble
429 U.S. 97 (Supreme Court, 1976)
West v. Atkins
487 U.S. 42 (Supreme Court, 1988)
Erickson v. Pardus
551 U.S. 89 (Supreme Court, 2007)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Sealock v. State Of Colorado
218 F.3d 1205 (Tenth Circuit, 2000)
Oxendine v. Kaplan
241 F.3d 1272 (Tenth Circuit, 2001)
Garrett v. Stratman
254 F.3d 946 (Tenth Circuit, 2001)
Mata v. Saiz
427 F.3d 745 (Tenth Circuit, 2005)
Martinez v. Garden
430 F.3d 1302 (Tenth Circuit, 2005)
Anderson v. Blake
469 F.3d 910 (Tenth Circuit, 2006)
Smith v. United States
561 F.3d 1090 (Tenth Circuit, 2009)
Martinez v. Aaron
570 F.2d 317 (Tenth Circuit, 1978)
Hall v. Bellmon
935 F.2d 1106 (Tenth Circuit, 1991)
Handy v. Price
996 F.2d 1064 (Tenth Circuit, 1993)
Clark v. Colbert
895 F.3d 1258 (Tenth Circuit, 2018)
Paugh v. Uintah County
47 F.4th 1139 (Tenth Circuit, 2022)

Cite This Page — Counsel Stack

Bluebook (online)
Stewart v. Dominicis, Counsel Stack Legal Research, https://law.counselstack.com/opinion/stewart-v-dominicis-ksd-2024.